BioSpace News Archive

CONMED Corporation (Nasdaq: CNMD) today announced financial results for the third quarter ended September 30, 2018.

Chief Financial Officer Toby Schilke and Interim Head of Commercial - Aesthetics & Therapeutics Dustin Sjuts to assume roles on November 5

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced third quarter 2018 financial results.

Company plans to pursue accelerated development pathway for LentiGlobinTM in sickle cell disease (SCD)

– New Commitment by Great Point Partners Brings Proceeds of Transactions to $87 Million –

Brings Together Highly Accurate Short- and Long-Read Sequencing Technologies, Paving the Path to a More Perfect View of a Genome

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that the Company’s Menin-MLLr program will be featured during two presentations at the 60th American Society of Hematology (ASH) Annual Meeting

Health services administrator Tanir Ami has been named CEO of CARESTAR Foundation

Study shows retail clinics deliver on satisfaction and convenience, but they are an additional channel, rather than a complete substitute, for primary care

Aflac Incorporated announced today that it will webcast its 2019 outlook conference call at 9:00 a.m. (ET) on Monday, December 3, 2018.